Amol Akhade/LinkedIn
May 5, 2025, 10:37
Amol Akhade Launches Clinician Poll on Adjuvant Therapy for Breast Cancer
Amol Akhade, Senior Consultant Medical Oncologist and Hemato-Oncologist at Suyog Cancer Clinics and Reliance Hospitals, shared a post on X:
“Clinician Poll for ESMOBreast25.
42 y/o woman, post-surgery Breast Cancer:
- T1cN0M0, ER 5%, PR−, HER2−
- What’s your approach to adjuvant therapy?
- Oncotype DX
- Hormonal therapy or not?
- Drop your opinion and VOTE below!
Let’s see what the experts say: Yakup Ergün, Erika Hamilton, Sara Tolaney, Hope Rugo, Sarah Sammons, Oncology Brothers.
Would you like me to design a poll layout or graphic to go with it?
- Yes for both
- No for Both
- Yes – oncotype – No -HT
- No- Oncotype – Yes -HT.”
More posts featuring Amol Akhade.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 5, 2025, 13:42
May 5, 2025, 13:40
May 5, 2025, 13:18
May 5, 2025, 12:53
May 5, 2025, 12:33
May 5, 2025, 12:20